The introduction of PCR technology to the molecular diagnosis of genetic diseases has increased the speed and range of DNA tests available. Previous analyses of dystrophin gene mutations were time consuming, taking weeks to complete, and used radioisotopic methods. Further developments in DNA amplification and post-amplification techniques have made conventional tube PCR redundant. The rapid methodologies described enable the efficient screening of large populations for genetic disorders, although precautions must be taken when analysing the PCR products. (J Med Genet 1993;30:60-1) 
Duchenne and Becker muscular dystrophies (MD) represent the most common and serious heritable neuromuscular disorders. Deletion mutations of the dystrophin gene, consisting of approximately 70 exons which span over 2 megabases of chromosome Xp, are described in 60% of reported MD cases.' Rapid analysis of the exon composition of a MD patient has been made possible by the polymerase chain reaction (PCR). Multiplex (fig 2) , opposite to the observed order in an agarose gel (fig 1) . Polyacrylamide was initially chosen as a gel matrix in this application for the benefits of cost, speed of resolution, densitometry scanning, and alternative silver staining for low product quantities. 
